GLP-1 Weight-Loss Pens Explained: Mounjaro vs Wegovy
How satiety-hormone medicines actually work, who they suit — and why medical supervision is the whole point.
Quick answer
What are GLP-1 weight-management medicines?
GLP-1–based medicines can support weight management for some adults who meet clinical criteria. Semaglutide acts on GLP-1; tirzepatide acts on GIP and GLP-1. The choice should not be based on which drug looks strongest online: medical history, contraindications, current medicines, side effects, goals and follow-up all matter. These are prescription medicines, results vary, and weight can return after treatment stops.
- Suitable for
- Adults who meet clinical criteria after a physician reviews health history, medicines and goals.
- What to expect
- Appetite and weight responses vary; ongoing nutrition, activity and follow-up remain important.
- Risks
- Nausea, vomiting, diarrhoea or constipation may occur; assessment is needed for contraindications and serious symptoms.
- Downtime
- There is no procedural wound, but dose-adjustment symptoms can disrupt eating, hydration or daily activity.
- When to see a doctor
- Before starting or switching medicine, and promptly for persistent vomiting, dehydration, severe abdominal pain or allergic symptoms.
Weight-loss pens have gone from diabetes clinics to dinner-table conversation. Behind the hype is real science: medicines that mimic your own satiety hormones, quieting the food noise that diets alone rarely silence. They are powerful tools — and tools work best, and safest, in trained hands.
What is GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating — it tells the brain "we are full", slows stomach emptying and helps regulate blood sugar. GLP-1 medicines are lab-made versions that deliver this signal steadily, as a simple once-weekly injection pen.
How it changes eating
- Appetite quiets down — smaller portions satisfy
- Cravings and "food noise" fade — less constant thinking about food
- Fullness lasts longer — slower stomach emptying
- Blood sugar steadies — fewer energy crashes that trigger snacking
Mounjaro vs Wegovy — the honest comparison
Wegovy (semaglutide) activates the GLP-1 pathway; large trials showed roughly 15% average body-weight reduction. Mounjaro (tirzepatide) activates GLP-1 plus GIP — a dual mechanism with trials averaging around 20%. Both are once-weekly pens with step-up dosing. Which fits you depends on health history, tolerance and budget — a doctor decision, not a trend decision. Hori offers both as supervised programs: Mounjaslim and WegoSlim.
Who it suits — and who it does not
Candidates are typically adults with a BMI in the obesity range, or overweight with weight-related conditions — confirmed by a doctor after screening. It is not for pregnancy or those planning it, people with a history of medullary thyroid cancer or MEN2, pancreatitis, and several other conditions your doctor will check. It is also not a shortcut for someone a few kilograms from a beach goal.
Side effects, told straight
Most common: nausea, constipation and reflux — usually during dose escalation, easing as the body adapts. The quieter risk is muscle loss when weight drops fast: protein targets and strength training are part of any good program. Rare but serious issues (pancreatitis, gallbladder) are exactly why check-ins matter.
The pen starts the change; the plan around it decides whether the change lasts.
Why doctor-supervised, not DIY
Four reasons: screening (ruling out contraindications), titration (stepping the dose to balance results and side effects), body-composition monitoring (protecting muscle while fat drops), and the exit plan (tapering with nutrition and training so results survive stopping). Online pens skip all four — and counterfeits are common.
The short version
- GLP-1 medicines mimic satiety hormones — appetite and food noise quiet down.
- Trials: ~15% average loss with semaglutide, ~20% with tirzepatide, over 12–18 months.
- Screening, titration, muscle protection and an exit plan are why supervision matters.
Frequently asked questions
Will the weight come back when I stop?+
Without a plan, often yes. A staged taper with nutrition and strength training — the exit plan — is how results are kept long-term.
Can I just buy a pen online?+
Strongly discouraged. These medicines need screening, staged dosing and side-effect monitoring by a doctor — and online products carry real counterfeit risk.
How fast will I see results?+
Appetite typically quiets within the first weeks; visible weight change builds over 3–6 months, with study averages of 15–20% at 12–18 months alongside lifestyle change.
Who should not use GLP-1?+
Pregnancy or planning it, history of medullary thyroid cancer or MEN2, pancreatitis, and other conditions your doctor screens for before starting.
